27.03.2015 • News

AkzoNobel to Invest in Organic Peroxide Operations in the US and Europe

AkzoNobel has announced plans to invest more than €20 million in its organic peroxide production facilities in Mons, Belgium, and Houston (Pasadena), Texas, in the US.

In Mons, the company is introducing new technologies to increase efficiency at the site, which will result in increased capacity. The investment is part of a plan to establish a modern, centralized hub which can serve AkzoNobel's broad base of European and global customers more efficiently and effectively.

In Houston, the company is implementing a new site-wide process control system which is expected to significantly improve capacity and operational efficiencies while positioning the site to meet the increasing demands of US customers. Embedding efficiencies in the Pasadena operations will help the company to enhance its competitive position in the region, as well as supporting the manufacturing growth of its customers in the US, specifically in the Gulf Coast area.

Werner Fuhrmann, AkzoNobel's Executive Committee member responsible for Specialty Chemicals:

"Our Organic Peroxides business is a reliable performer in AkzoNobel's specialty chemicals portfolio. We have many leading market positions and a strong network of operations to meet the demands of a global marketplace. These targeted investments are focused on making gains in many areas, including operational efficiencies, which will help to strongly position our business for further growth in the polymer industry."

AkzoNobel is a leading producer of organic peroxides. The company's products are used by customers to manufacture polymers found in a wide range of applications, including plastic films, thermoplastics, natural and synthetic rubber, PVC used in pipes, and pharmaceutical products.

AkzoNobel operates a total of 11 organic peroxide manufacturing plants globally, including facilities in Los Reyes, Mexico; Ningbo, China; Mahad, India; and Itupeva, Brazil.

 

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.